UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in oncolytic adenovirus therapy for pancreatic cancer

Cancer letters, 2018-10, Vol.434, p.56-69

2018

Volltextzugriff (PDF)

Designer Oncolytic Adenovirus: Coming of Age

Cancers, 2018-06, Vol.10 (6), p.201

2018

Volltextzugriff (PDF)

Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1265

2024

Volltextzugriff (PDF)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses

Frontiers in molecular biosciences, 2022-06, Vol.9, p.901392-901392

2022

Volltextzugriff (PDF)

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

Expert opinion on therapeutic targets, 2012-10, Vol.16 (10), p.945-958

2012

Volltextzugriff (PDF)

Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo

Clinical cancer research, 2009-03, Vol.15 (5), p.1730-1740

2009

Volltextzugriff (PDF)

GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells

American journal of physiology: Gastrointestinal and liver physiology, 2007-05, Vol.292 (5), p.G1366-G1375

2007

Volltextzugriff (PDF)

Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers

Clinical cancer research, 2010-01, Vol.16 (2), p.541-553

2010

Volltextzugriff (PDF)

Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer

Scientific reports, 2019-09, Vol.9 (1), p.1-12, Article 12840

2019

Volltextzugriff (PDF)

Oncolytic adenovirus-mediated therapy for prostate cancer

Oncolytic virotherapy, 2016-01, Vol.5, p.45-57

2016

Volltextzugriff (PDF)

Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells

Endocrine-related cancer, 2013-10, Vol.20 (5), p.633-647

2013

Volltextzugriff (PDF)

Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region

PloS one, 2012-10, Vol.7 (10), p.e46617-e46617

2012

Volltextzugriff (PDF)

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

Nature biotechnology, 2003-11, Vol.21 (11), p.1328-1335

2003

Volltextzugriff (PDF)

Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts

Human gene therapy, 2010-10, Vol.21 (10), p.1311-1325

2010

Volltextzugriff (PDF)

Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models

Human gene therapy, 2012-09, Vol.23 (9), p.1003-1015

2012

Volltextzugriff (PDF)

Adenoviral gene expression and replication in human tumor explant models

Methods in molecular biology (Clifton, N.J.), 2012, Vol.797, p.65

Halldén, Gunnel

2012

Volltextzugriff (PDF)

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1523-1531

2005

Volltextzugriff (PDF)

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models

International journal of molecular sciences, 2022-08, Vol.23 (16), p.8884

2022

Volltextzugriff (PDF)

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models

Viruses, 2022-05, Vol.14 (5), p.1006

2022

Volltextzugriff (PDF)

Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947

Clinical cancer research, 2008-10, Vol.14 (20), p.6505

2008

Volltextzugriff (PDF)

The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11

Oncotarget, 2016-03, Vol.7 (13), p.15703-15724

2016

Volltextzugriff (PDF)

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Pharmacological reports, 2023-06, Vol.75 (3), p.570-584

2023

Volltextzugriff (PDF)

Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy

Acta biomaterialia, 2021-10, Vol.134, p.593-604

2021

Volltextzugriff (PDF)

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Pharmacological reports, 2023-06, Vol.75 (3), p.753-753

2023

Volltextzugriff (PDF)

A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses

Clinical cancer research, 2005-01, Vol.11 (1), p.351-360

2005

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(67)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in oncolytic adenovirus therapy for pancreatic cancer

Designer Oncolytic Adenovirus: Coming of Age

Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo

GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells

Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers

Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer

Oncolytic adenovirus-mediated therapy for prostate cancer

Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells

Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts

Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models

Adenoviral gene expression and replication in human tumor explant models

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models

Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947

The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses

Suchergebnisse filtern